CANNABIS AND CANNABIDIOL: RETAIL COMPANIES
Another milestone recently passed for Canadian marijuana stocks was the introduction of Tilray (TLRY), the first such company to make an initial public offering. Tilray, which advertises itself as a one-stop medical cannabis company, was valued at $ 17 a share, and quickly skyrocketed more than 21% after its IPO. So, I gave a site for your use https://www.momcanada.net/best-weed-delivery-toronto/.
There are several other fairly well-known medical marijuana companies in Canada that you might want to take a look at, such as Med ReLeaf (MEDFF) and Aphria (APHQF).
Unfortunately, medical cannabis is not as widespread in our country as in Canada, and the US market does not match Canadian indicators. That is why people are eager to find Canadian companies, of which there are many more.
Although recreational marijuana is much less common than medical marijuana, its approval rate is at the highest ever in public opinion polls on the subject. Cannabis, including recreational cannabis, is 100% legal in nine American states and Washington, DC. Canada is close to legalizing recreational marijuana, and Prime Minister Justin Trudeau continues to announce plans to pass legislation in the summer of 2018.
Medical cannabis companies will certainly benefit from new customers, but this will also require additional costs to meet demand. This is important to remember: there is an opportunity to make money, but costs are inevitable. Not all cannabis stocks will be profitable just because cannabis is legalized.
On the other hand, some companies were preparing for the day when recreational marijuana would become legal and distribution would have to expand, and such companies might be worth taking a look at. Over the years Scott's Miracle-Gro, Co. (SMG - Get Report) has acquired several cannabis companies including General Hydroponics and Sunlight Supply.
Another interesting company to look out for has no public shares - yet. MedMen Enterprises is a highly successful cannabis retailer with dispensaries in several states. MedMen has announced that it plans to go public and also announced the go-to-buy procedure for OpenPartner Media Corporation, which is currently not listed. It may be worth paying attention to the details and the planned timeline for the transformation into a public company.
Exchange traded funds
As stocks in marijuana companies become more common, specialized exchange-traded funds also come into use. They allow you to trade multiple securities in one fund, providing portfolio diversification. These tempting tools appeared, however, even later than stocks of companies working with marijuana. So, if banks are still wary of stocks in individual cannabis-related companies, they will definitely be wary of fund stocks in several such companies.
So be on the lookout. The Horizons family of funds has a cannabis stock fund. The Horizons Marijuana Life Sciences ETF (HMMJ) fund is popular - it includes shares of the previously mentioned companies - Aurora and Canopy Growth.
ETFMG Alternative Harvest ETF (MJ - Get Report) is a fund that consists exclusively of shares of marijuana-related companies, and the Evolve Marijuana ETF (TSX: SEED), which appeared a little later, consists almost entirely of shares of Canadian companies and is traded on the Toronto Stock Exchange ...
Due to the fact that many well-known cannabis producers are located in Canada, dependence on Canadian companies and the economy is considered another risk factor for ETFs. If something happens to the Canadian economy, the shares of many Canadian companies will collapse at once.
Hemp growers stock: industrial hemp
Do you want to be one of the first to invest in the industry and profit from cannabis? If you want to invest directly in cannabis production, the opportunity exists.
Founded in 2008, Hemp Inc. (HEMP) aims to become a one-stop cannabis business, including growing, extracting ingredients, processing fibers, even selling hemp care products. The hemp grower may have an important milestone as Senate Majority Leader Mitch McConnell recently announced the pending bill that, if passed, would legalize industrial hemp at the federal level. If the bill passes, a company like Hemp Inc., which has been around for a long time in the US, is likely to gain an edge over its competitors.
How to invest in stocks of companies dealing with marijuana in 2018, while minimizing risks?
A smart bet when dealing with a marijuana investment may be to find stocks in a company for which cannabis is only part of its business, or even only indirectly related to its business.
For example, Abbvie Inc. (ABBV - Get Report), is a conventional pharmaceutical company. However, it sells, among other things, Marinol, an FDA-approved synthetic cannabinoid designed to prevent nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY - Get Report) is a pharmaceutical company licensed to sell synthetic cannabis by the United States Drug Enforcement Administration (DEA), although it has donated funds to an anti-marijuana legalization group in the past.
Remember Canopy Growth? Constellation Brands Inc. (STZ - Get Report), a maker of several successful beers and spirits, including Corona, recently acquired a 9.9% minority stake in Canopy Growth. This is certainly a good option for those interested in cannabis stocks but prefer safer investments and better-known companies.
Want to invest in cannabis without investing in cannabis at all? Companies like Kush Bottles (KSHB) might be your option. Kush Bottles does not grow, produce or sell cannabis. She is engaged in the wholesale of cannabis bottles, packaging and auxiliary materials to points of sale, growers, etc. A fast-growing company with decent sales is an indirect way to gamble in the cannabis market.
All this, of course, carries its own risks, both industry-wide and specific to an individual company. Cannabis stocks are more volatile than average stocks, and the legality of cannabis is always difficult to pinpoint. The world for marijuana is changing, and how you think about the direction of change will determine your acceptability of the investment.